Crossmark

Comment on “Safety of Physostigmine for Pediatric Antimuscarinic Poisoning”

Crossref DOI link: https://doi.org/10.1007/s13181-024-01022-z

Published Online: 2024-07-30

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pires, Kyle D. https://orcid.org/0000-0001-6247-8761
Goldfrank, Lewis R.
License Information

Text and Data Mining valid from 2024-07-30

Version of Record valid from 2024-07-30
More Information

Article History

Received: 28 February 2024

Revised: 8 May 2024

Accepted: 17 May 2024

First Online: 30 July 2024